| Aug 12 |
Gossamer Bio (GOSS) Q2 Earnings and Revenues Lag Estimates
|
| Aug 12 |
Gossamer Bio GAAP EPS of $0.22, revenue of $88.8M
|
| Aug 12 |
Gossamer Bio: Q2 Earnings Snapshot
|
| Aug 12 |
Gossamer Bio Announces Second Quarter 2024 Financial Results and Provides Business Update
|
| Jul 25 |
Why Is Gossamer Bio, Inc. (GOSS) the Best One-Dollar Stock to Buy Now?
|
| Jun 25 |
Gossamer Bio's Clean Safety Profile Differentiates It From Merck, Analyst Says
|
| Jun 25 |
Gossamer Bio And 2 Other Stocks Under $2 Insiders Are Buying
|
| Jun 24 |
Gossamer Bio a new outperform at Oppenheimer on seralutinib for PAH
|
| Jun 13 |
The Penny Stock Pundits: 3 Companies Poised to Become the Talk of Wall Street
|
| Jun 7 |
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
|
